EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis

Brett Cohen, Saran T Singh, Aarjuv Majmundar, Bryce Allen, Brendan Boardwine

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.th179 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Hypertension, 2026-10. Verfasst von Brett Cohen und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Time in target range (TTR) for systolic blood pressure (SBP) quantifies the consistency of blood pressure control over time and predicts cardiovascular events. Whether higher SBP-TTR protects the kidney is unsettled: a 2025 meta-analysis pooled TTR against cardiovascular and mortality endpoints but judged the renal evidence insufficient to pool. We performed the first meta-analysis of SBP-TTR and adverse kidney outcomes.

Methods

We systematically searched PubMed and Europe PMC (through June 2026) with backward and forward citation chaining for cohort studies and post-hoc randomized trial analyses reporting an adjusted association between SBP-TTR and a renal endpoint; non-blood-pressure "time in range" exposures (anticoagulation, glucose, body weight) were excluded. The primary analysis pooled adjusted hazard ratios (HRs) per 1-standard-deviation (SD) higher SBP-TTR for a composite of adverse kidney events (chronic kidney disease [CKD] progression, incident CKD, or acute kidney injury [AKI]) using random-effects (REML) models with Knapp-Hartung variance; heterogeneity was summarized with I-squared. A secondary analysis pooled highest-versus-lowest TTR category contrasts. Certainty was graded with GRADE.

Results

Three cohorts (SPRINT, STEP, and KNOW-CKD; 15,667 participants, approximately 1,559 events) reported per-1-SD estimates. Higher SBP-TTR was associated with lower risk of adverse kidney events (pooled HR 0.89, 95% CI 0.85-0.93; I-squared 0%). The association was consistent when restricted to chronic CKD progression (HR 0.90, 95% CI 0.84-0.95) and across five studies in a highest-versus-lowest category analysis (HR 0.72, 95% CI 0.64-0.82). Leave-one-out estimates were stable (0.88-0.90).

Conclusions

Greater consistency of systolic blood pressure control, measured as time in target range, was associated with roughly 11% lower risk of adverse kidney events per SD increase, with no detectable heterogeneity and a consistent dose-response gradient (moderate-certainty evidence, GRADE). Findings are limited by the small number of cohorts and possible reverse causation. SBP-TTR may serve as a modifiable quality metric for kidney protection and warrants prospective evaluation.

Zitieren

APA

Cohen, B., Singh, S. T., Majmundar, A., Allen, B., & Boardwine, B. (2026). Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th179

Vancouver

Cohen B, Singh ST, Majmundar A, Allen B, Boardwine B. Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th179

BibTeX
@article{Cohen2026,
  author = {Cohen, Brett and Singh, Saran T and Majmundar, Aarjuv and Allen, Bryce and Boardwine, Brendan},
  title = {Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.th179}
}
Kostenlos starten →